Pharma cos' revenue to grow 6-8% in FY24: ICRA
Revenue growth will be driven by steady performance across key markets — the U.S. and India — and some recovery in growth in the European market.
indian pharma
April 2023
January 2023
August 2022
July 2022
March 2022
November 2021
October 2021
USFDA inspections to be less disruptive for Indian pharma sector: Report
Indian pharma companies have increasingly de-risked their operations by slowly and steadily increasing sales to non-US markets, says India Ratings and Research.
Sluggish exports to hit pharma revenue growth: CRISIL
The domestic formulations market is expected to grow 7-9% this fiscal.
Indian pharma majors to hit US growth bump in FY23
The revenue growth of about 16 leading Indian pharmaceutical companies is estimated to moderate to 6-7% in FY23, says ICRA.
Russia-Ukraine war: India's pharma, fertiliser firms most vulnerable
Ind-Ra estimates that higher food, fertiliser and oil prices are likely to put pressure on the subsidy allocation by the Indian government.
Competitors Within
Home-grown smaller players are giving biggies a run for their money in the US generics market.
Quality issues remain for Indian pharma companies: USFDA
The problems faced by FDA’s investigators in India are similar to those around the world, US Food and Drug Administration spokesperson Jeremy Kahn tells Fortune India.
